Tango Therapeutics, Inc.

Tango Therapeutics Inc. is a biotechnology company that focuses on the discovery and development of precision cancer medicines. Its primary objective is to identify novel therapeutic targets and develop treatments based on synthetic lethality, an approach that exploits vulnerabilities within cancer cells for effective treatment. Tango Therapeutics operates in the biotechnology and healthcare sectors, impacting areas such as cancer research, drug development, and personalized medicine. The company harnesses advanced technologies in genomics and bioinformatics to uncover potential drug candidates that are specifically tailored to the genetic profile of different cancer types. Tango Therapeutics plays a crucial role in the treatment landscape by providing innovative solutions that are designed to improve outcomes for cancer patients. Established as a leader in precision oncology, the company contributes to the growing field of targeted therapies, aiming to transform how cancer is treated across the globe.